7506-36-7 Usage
Uses
Used in Dye and Pigment Production:
2-[(4-Ethoxyphenyl)amino]methyl-1H-isoindole-1,3(2H)-dione is utilized as a dye intermediate in the production of a wide range of dyes and pigments. Its unique color and chemical structure contribute to the development of diverse colorants for various applications.
Used in Pharmaceutical Synthesis:
2-[(4-Ethoxyphenyl)amino]methyl-1H-isoindole-1,3(2H)-dione also plays a role in the synthesis of pharmaceuticals, where its structural features can be leveraged to create new drugs or improve existing ones.
Used in Organic Chemistry Research:
2-[(4-Ethoxyphenyl)amino]methyl-1H-isoindole-1,3(2H)-dione serves as a research tool in the field of organic chemistry, aiding scientists in understanding the properties and reactions of similar compounds, thus advancing the development of new chemical processes and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 7506-36-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,0 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7506-36:
(6*7)+(5*5)+(4*0)+(3*6)+(2*3)+(1*6)=97
97 % 10 = 7
So 7506-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H16N2O3/c1-2-22-13-9-7-12(8-10-13)18-11-19-16(20)14-5-3-4-6-15(14)17(19)21/h3-10,18H,2,11H2,1H3
7506-36-7Relevant academic research and scientific papers
Isoindole-1,3-dione derivatives as RSK2 inhibitors: Synthesis, molecular docking simulation and SAR analysis
Zhou, Wei,Li, Shiliang,Lu, Weiqiang,Yuan, Jun,Xu, Yufang,Li, Honglin,Huang, Jin,Zhao, Zhenjiang
supporting information, p. 292 - 296 (2016/03/01)
RSK2 (p90 ribosomal S6 kinase 2) is a serine/threonine kinase expressed in a variety of cancers. Molecular-targeted inhibition of RSK2 as a potential therapeutic strategy for human cancers has been documented. In this work, a series of isoindole-1,3-dione derivatives as novel RSK2 inhibitors were designed and synthesized from a hit discovered in our previous study. Some compounds were confirmed to be moderately potent RSK2 inhibitors with IC50 values of about 0.5 μM. Structure-activity relationship analysis and binding mode studies by molecular docking were performed.
